Search Results - "Noy, Ariela"

Help or hindrance? Rituximab maintenance and COVID by Noy, Ariela

“…Not available.Not available…”
Get full text

Discordant SARS-CoV-2 spike protein receptor binding domain IgG and neutralization after B-cell depletion by Noy, Ariela, Vardhana, Santosha A

Get full text

Telomeres: The Long and Short of Developing Non-Hodgkin Lymphoma by Noy, Ariela

“…Chromosomal integrity is vital to the life span of the dividing cell. Telomeres are tandem sequences at chromosome ends that provide protection for the genetic…”
Get full text

PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study by Moskowitz, Alison J, Dr, Schöder, Heiko, Prof, Yahalom, Joachim, Prof, McCall, Susan J, NP, Fox, Stephanie Y, BS, Gerecitano, John, MD, Grewal, Ravinder, MD, Hamlin, Paul A, MD, Horwitz, Steven, MD, Kobos, Rachel, MD, Kumar, Anita, MD, Matasar, Matthew, MD, Noy, Ariela, MD, Palomba, M Lia, MD, Perales, Miguel-Angel, MD, Portlock, Carol S, Prof, Sauter, Craig, MD, Shukla, Neerav, MD, Steinherz, Peter, Prof, Straus, David, Prof, Trippett, Tanya, MD, Younes, Anas, Prof, Zelenetz, Andrew, Prof, Moskowitz, Craig H, Prof

“…Summary Background Pre-transplantation18 F-fluorodeoxyglucose (FDG) PET-negativity is one of the strongest predictors of outcome after high-dose therapy and…”
Get full text

Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups by Batlevi, Connie L., Sha, Fushen, Alperovich, Anna, Ni, Ai, Smith, Katy, Ying, Zhitao, Soumerai, Jacob D., Caron, Philip C., Falchi, Lorenzo, Hamilton, Audrey, Hamlin, Paul A., Horwitz, Steven M., Joffe, Erel, Kumar, Anita, Matasar, Matthew J., Moskowitz, Alison J., Moskowitz, Craig H., Noy, Ariela, Owens, Colette, Palomba, Lia M., Straus, David, von Keudell, Gottfried, Zelenetz, Andrew D., Seshan, Venkatraman E., Younes, Anas

“…Patients with follicular lymphoma (FL) frequently require multiple treatments during their disease course; however, survival based on lines of treatment…”
Get full text

Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse by Bobillo, Sabela, Joffe, Erel, Sermer, David, Mondello, Patrizia, Ghione, Paola, Caron, Philip C., Hamilton, Audrey, Hamlin, Paul A., Horwitz, Steven M., Kumar, Anita, Matasar, Matthew J., Batlevi, Connie L., Moskowitz, Alison, Noy, Ariela, Owens, Collette N., Palomba, M. Lia, Straus, David, von Keudell, Gottfried, Dogan, Ahmet, Zelenetz, Andrew D., Seshan, Venkatraman E., Younes, Anas

“…Although methotrexate (MTX) is the most widely used therapy for central nervous system (CNS) prophylaxis in patients with diffuse large B-cell lymphoma…”
Get full text

Phase II Study of Bendamustine in Relapsed and Refractory Hodgkin Lymphoma by MOSKOWITZ, Alison J, HAMLIN, Paul A, GRAUSTEIN, Tricia, ZELENETZ, Andrew D, MOSKOWITZ, Craig H, PERALES, Miguel-Angel, GERECITANO, John, HORWITZ, Steven M, MATASAR, Matthew J, NOY, Ariela, LIA PALOMBA, Maria, PORTLOCK, Carol S, STRAUS, David J

“…Limited data exist regarding the activity of bendamustine in Hodgkin lymphoma (HL). This phase II study evaluated the efficacy of bendamustine in relapsed and…”
Get full text

Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapse by Kumar, Anita, Sha, Fushen, Toure, Ahmed, Dogan, Ahmet, Ni, Andy, Batlevi, Connie L., Palomba, Maria Lia M., Portlock, Carol, Straus, David J., Noy, Ariela, Horwitz, Steven M., Moskowitz, Alison, Hamlin, Paul, Moskowitz, Craig H., Matasar, Matthew J., Zelenetz, Andrew D., Younes, Anas

“…As the survival of patients with mantle cell lymphoma (MCL) continues to improve, patients are increasingly being treated with multiple regimens. However,…”
Get full text

Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients by Barta, Stefan K., Xue, Xiaonan, Wang, Dan, Tamari, Roni, Lee, Jeannette Y., Mounier, Nicolas, Kaplan, Lawrence D., Ribera, Josep-Maria, Spina, Michele, Tirelli, Umberto, Weiss, Rudolf, Galicier, Lionel, Boue, Francois, Wilson, Wyndham H., Wyen, Christoph, Oriol, Albert, Navarro, José-Tomás, Dunleavy, Kieron, Little, Richard F., Ratner, Lee, Garcia, Olga, Morgades, Mireia, Remick, Scot C., Noy, Ariela, Sparano, Joseph A.

“…Limited comparative data exist for the treatment of HIV-associated non-Hodgkin lymphoma. We analyzed pooled individual patient data for 1546 patients from 19…”
Get full text

Remission of a primary effusion lymphoma with initiation of highly active antiretroviral therapy and antiviral therapy in a previously untreated HIV-positive patient by Musinsky, Jacob, Noy, Ariela

Get full text

Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell Lymphoma by MOSKOWITZ, Craig H, SCHÖDER, Heiko, HORWITZ, Steven, WEAVER, Sarah A, MEIKLE, Jessica L, FILIPPA, Daniel A, CARAVELLI, James F, HAMLIN, Paul A, ZELENETZ, Andrew D, TERUYA-FELDSTEIN, Julie, SIMA, Camelia, IASONOS, Alexia, PORTLOCK, Carol S, STRAUS, David, NOY, Ariela, PALOMBA, Maria L, O'CONNOR, Owen A

“…PURPOSE In studies of diffuse large B-cell lymphoma, positron emission tomography with [(18)F]fluorodeoxyglucose (FDG-PET) performed after two to four cycles…”
Get full text

Long-Term Outcomes and Patterns of Relapse of Early-Stage Extranodal Marginal Zone Lymphoma Treated With Radiation Therapy With Curative Intent by Teckie, Sewit, MD, Qi, Shunan, MD, Lovie, Shona, MPH, Navarrett, Scott, BS, Hsu, Meier, MS, Noy, Ariela, MD, Portlock, Carol, MD, Yahalom, Joachim, MD

“…Purpose To report the long-term outcome and patterns of relapse of a large cohort of marginal zone lymphoma (MZL) patients treated with curative-intent…”
Get full text

Phase II Trial of Imatinib in AIDS-Associated Kaposi's Sarcoma: AIDS Malignancy Consortium Protocol 042 by KOON, Henry B, KROWN, Susan E, NOY, Ariela, LEE, Jeannette Y, HONDA, Kord, RAPISUWON, Suthee, ZHENGHE WANG, ABOULAFIA, David, REID, Erin G, RUDEK, Michelle A, DEZUBE, Bruce J

“…Kaposi's sarcoma (KS) is a disease of multifocal vascular proliferation that requires infection with KS herpes virus (KSHV/HHV-8). Activation of the c-kit and…”
Get full text

Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients by Laracy, Justin C, Yan, Judy, Steiger, Samantha N, Tan, Carrie A, Cohen, Nina, Robilotti, Elizabeth V, Fender, Jerome, Cohen, Sara, Korde, Neha, Lee-Teh, Melissa, Noy, Ariela, Oved, Joseph H, Roeker, Lindsey E, Shah, Gunjan, Babady, N Esther, Kamboj, Mini, Seo, Susan K

“…AZD7442 (tixagevimab-cilgavimab) is a combination of two human monoclonal antibodies for pre-exposure prophylaxis of severe acute respiratory syndrome…”
Get full text

Diffuse large B-cell lymphoma involving osseous sites: utility of response assessment by PET/CT and good longterm outcomes by Ghione, Paola, Ahsanuddin, Salma, Luttwak, Efrat, Varela, Sabela Bobillo, Nakajima, Reiko, Michaud, Laure, Gupta, Kanika, Navitski, Anastasia, Straus, David, Palomba, M Lia, Moskowitz, Alison, Noy, Ariela, Hamlin, Paul, Matasar, Matthew, Kumar, Anita, Falchi, Lorenzo, Yahalom, Joachim, Horwitz, Steven, Zelenetz, Andrew, Younes, Anas, Salles, Gilles, Schöder, Heiko, Joffe, Erel

“…Osseous involvement by diffuse large B-cell lymphoma (DLBCL-bone) is a heterogeneous disease. There is limited data regarding response assessment by positron…”
Get full text

Randomized Controlled Trial of a Video Decision Support Tool for Cardiopulmonary Resuscitation Decision Making in Advanced Cancer by VOLANDES, Angelo E, PAASCHE-ORLOW, Michael K, CHANG, Yuchiao, LOPEZ, Lenny, KEMENY, Margaret, BULONE, Linda, MANN, Eileen, MISRA, Sumi, PEACHEY, Matt, ABBO, Elmer D, EICHLER, April F, EPSTEIN, Andrew S, MITCHELL, Susan L, NOY, Ariela, LEVIN, Tomer T, TEMEL, Jennifer S, EL-JAWAHRI, Areej, DELIGHT DAVIS, Aretha, BARRY, Michael J, HARTSHORN, Kevan L, JACKSON, Vicki Ann, GILLICK, Muriel R, WALKER-CORKERY, Elizabeth S

“…Decision making regarding cardiopulmonary resuscitation (CPR) is challenging. This study examined the effect of a video decision support tool on CPR…”
Get full text

Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: real-life experience by Cassanello, Giulio, Drill, Esther, Rivas-Delgado, Alfredo, Okwali, Michelle, Isgor, Irem, Caron, Philip C, Epstein-Peterson, Zachary, Ghione, Paola, Hamlin, Paul, Lue, Jennifer, Horwitz, Steven M, Intlekofer, Andrew M, Johnson, William, Kumar, Anita, Moskowitz, Alison, Noy, Ariela, Owens, Colette, Palomba, Lia M, Torka, Pallawi, Galera, Pallavi, Zelenetz, Andrew D, Salles, Gilles, Falchi, Lorenzo

“…The combination of rituximab and lenalidomide (R-len) stands as an established treatment for relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL)…”
Get full text

Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis by Johnson, William T, Epstein-Peterson, Zachary D, Ganesan, Nivetha, Pak, Timothy, Chang, Tiffany, Dao, Phuong, Moskowitz, Alison J, Stuver, Robert N, Ghione, Paola, Galasso, Natasha, Khan, Niloufer, Palomba, M Lia, Caron, Philip C, Kumar, Anita, Tamari, Roni, Lue, Jennifer K, Noy, Ariela, Falchi, Lorenzo, Intlekofer, Andrew M, Gyurkocza, Boglarka, Perales, Miguel-Angel, Scordo, Michael, Herskovits, A Zara, Salles, Gilles, Vardhana, Santosha A, Horwitz, Steven M

Get full text

Prephase rituximab/prednisone therapy and aging-related, proinflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma by Lin, Richard J, Owens, Colette N, Drill, Esther, Iannotta, Augustine, Oliveros, Mayan, Schick, Dylan L, Noy, Ariela, Gerecitano, John F, Drullinsky, Pamela R, Caron, Philip C, Kumar, Anita, Matasar, Matthew J, Moskowitz, Craig, Korc-Grodzicki, Beatriz, Zelenetz, Andrew D, Salles, Gilles A, Hamlin, Paul A

“…Diffuse large B-cell lymphoma (DLBCL) predominantly affects older adults with suboptimal therapeutic outcomes due to increased treatment-related mortality and…”
Get full text

Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma by Sparano, Joseph A, Lee, Jeannette Y, Kaplan, Lawrence D, Ramos, Juan Carlos, Ambinder, Richard F, Wachsman, William, Aboulafia, David, Noy, Ariela, Henry, David H, Ratner, Lee, Cesarman, Ethel, Chadburn, Amy, Mitsuyasu, Ronald

“…Four cycles of rituximab plus CHOP chemotherapy is as effective as 6 cycles in low-risk diffuse large B-cell lymphoma (DLBCL). Here we report a post-hoc…”
Get full text